CTRI Number |
CTRI/2023/08/057050 [Registered on: 29/08/2023] Trial Registered Prospectively |
Last Modified On: |
27/08/2023 |
Post Graduate Thesis |
Yes |
Type of Trial |
Interventional |
Type of Study
|
Drug Surgical/Anesthesia |
Study Design |
Randomized, Parallel Group Trial |
Public Title of Study
|
Effect of dexmeditomidine with combination of bupivacaine in paediatric caudal anaesthesia |
Scientific Title of Study
|
Comparison of two different dosage of dexmeditomidine with bupivacaine in paediatric caudal Anaesthesia for infraumbilical surgeries |
Trial Acronym |
|
Secondary IDs if Any
|
Secondary ID |
Identifier |
NIL |
NIL |
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
Name |
BGeetha Sindhuja |
Designation |
Junior Resident |
Affiliation |
Datta Meghe Institute of Higher Education and Research |
Address |
Department of Anaesthesia
Jawaharlal Nehru Medical College Sawangi (Meghe) Wardha MAHARASHTRA 442001 India |
Phone |
9492659773 |
Fax |
|
Email |
sindhugeetha8@gmail.com |
|
Details of Contact Person Scientific Query
|
Name |
Neeta Chaudhary |
Designation |
Professor |
Affiliation |
Datta Meghe Institute of Higher Education and Research |
Address |
Department of Anaesthesia
Jawaharlal Nehru Medical College Sawangi(Meghe) Wardha MAHARASHTRA 442001 India |
Phone |
878837832 |
Fax |
|
Email |
neetachaudhary1234@gmail.com |
|
Details of Contact Person Public Query
|
Name |
Neeta Chaudhary |
Designation |
Professor |
Affiliation |
Datta Meghe Institute of Higher Education and Research |
Address |
Department of Anaesthesia
Jawaharlal Nehru Medical College Sawangi(Meghe)
MAHARASHTRA 442001 India |
Phone |
878837832 |
Fax |
|
Email |
neetachaudhary1234@gmail.com |
|
Source of Monetary or Material Support
|
|
Primary Sponsor
|
Name |
Jawaharlal Nehru Medical College |
Address |
Department of Anaesthesia
Datta Meghe Institute of Higher Education and Research |
Type of Sponsor |
Private medical college |
|
Details of Secondary Sponsor
|
|
Countries of Recruitment
|
India |
Sites of Study
|
No of Sites = 1 |
Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
BGeetha Sindhuja |
Jawaharlal Nehru Medical College |
Department of Anaesthesia Wardha MAHARASHTRA |
9492659773
sindhugeetha8@gmail.com |
|
Details of Ethics Committee
|
No of Ethics Committees= 1 |
Name of Committee |
Approval Status |
Datta Meghe Institute of Medical Sciences |
Approved |
|
Regulatory Clearance Status from DCGI
|
|
Health Condition / Problems Studied
|
Health Type |
Condition |
Patients |
(1) ICD-10 Condition: N998||Other intraoperative and postprocedural complications and disorders of genitourinary system, (2) ICD-10 Condition: N998||Other intraoperative and postprocedural complications and disorders of genitourinary system, |
|
Intervention / Comparator Agent
|
Type |
Name |
Details |
Intervention |
Dexmedetomidine 1mcg/kg will be used as intervention |
In intervention group we will assess the effect of 1 mcg/kg dose of dexmedetomidine with bupivacaine in pediatric caudal block surgeries |
Comparator Agent |
dexmedetomidine 0.5 mcg/kg will be used as comparitive agent. |
In comparitive group dexmedetomidine 0.5 mcg/kg will be used. |
|
Inclusion Criteria
|
Age From |
6.00 Month(s) |
Age To |
6.00 Year(s) |
Gender |
Both |
Details |
Age group of 6 months to 6 years
ASA Class I & II patients.
Children posted for infraumbilical surgeries
|
|
ExclusionCriteria |
Details |
ASA grade 3, 4 and 5.
allergy to any of the study drug
Cardiac, Respiratory diseases
Hepatic, Renal dysfunction
developmental delay or mental retardation
Infection at the site of caudal block.
|
|
Method of Generating Random Sequence
|
Computer generated randomization |
Method of Concealment
|
Sequentially numbered, sealed, opaque envelopes |
Blinding/Masking
|
Participant Blinded |
Primary Outcome
|
Outcome |
TimePoints |
Caudal dexmeditomidine (1mcg/kg) with 0.25% bupivacaine for paediatric infra umbilical surgeries achieved significant post operative pain relief compared to caudal dexmeditomidine (0.5mcg/kg) with 0.25% bupivacaine. |
240 minutes |
|
Secondary Outcome
|
Outcome |
TimePoints |
Incidence of side effects was less in 0.5 mcg/kg dexmeditomidine group when compared to 1mcg/kg group |
240 minutes |
|
Target Sample Size
|
Total Sample Size="60" Sample Size from India="60"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
Phase of Trial
|
Phase 2 |
Date of First Enrollment (India)
|
30/09/2023 |
Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
Date of First Enrollment (Global) |
Date Missing |
Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
Estimated Duration of Trial
|
Years="2" Months="0" Days="0" |
Recruitment Status of Trial (Global)
|
Not Applicable |
Recruitment Status of Trial (India) |
Not Yet Recruiting |
Publication Details
|
N/A |
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
Brief Summary
|
Caudal epidural block is one of the most common regional techniques in paediatric anesthesia .Caudal block is a safe and reliable technique, easy to perform and has been foundto be very effective in children,we will conduct this study to compare two different dosages, 1μg/kg dexmedetomidine with bupivacaine during caudal epidural block which has been proved to increase analgesia duration in comparison with 0.5μg/kg dexmedetomidine as an adjuvant for duration of postoperative analgesia ,hemodynamic changes and adverse effects. |